摘要
脑卒中是最常见的急症之一,也是当前导致死亡的第二大原因。脑卒中的发生发展涉及一系列的免疫炎症反应,这与血细胞密切相关。近年来基于血常规的各类新型免疫炎症标志物在急性缺血性脑卒中的诊断、预后及并发症的评估预测中发挥重要作用,对指导急性缺血性脑卒中的干预治疗有着重要价值。本文就基于血常规的新型免疫炎症标志物与急性缺血性脑卒中的相关性研究进展作一综述。
Stroke is one of the most common emergencies and is currently the second leading cause of death.The occurrence and development of stroke involves a series of immune inflammatory reactions,which are closely related to blood cells.In recent years,various novel immunoinflammatory markers based on blood routine have played an important role in the diagnosis,prognosis,evaluation and prediction of complications of acute ischemic stroke,and have important value in guiding the intervention and treatment of acute ischemic stroke.This article reviews the research progress in the correlation between novel immunoinflammatory markers based on blood routine and acute ischemic stroke.
作者
黄凯
王美堂(审校)
HUANG Kai;WANG Meitang(Department of General Medicine,the First Affiliated Hospital of Naval Military Medical University,Shanghai,200433,China;Department of Emergency,the First Affiliated Hospital of the Naval Military Medical University)
出处
《临床急诊杂志》
CAS
2023年第11期604-608,共5页
Journal of Clinical Emergency
基金
海军军医大学第一附属医院临床学科创新项目(No:2020YXK038)。